Unichem Laboratories gets USFDA nod for Metronidazole tablets

Unichem Laboratories has received approval from the US Food & Drug Administration to sell generic Metronidazole tablets, an anti-infective agent, in the American market.

The approval is for Metronidazole in strengths of 250 mg and 500 mg, which are therapeutically equivalent to Flagyl Tablets of corresponding strengths of GD Searle LLC, the company said in a filing to the BSE.

The drug is an anti-infective agent used to treat a variety of bacterial and protozoal infections.

The product will be commercialised from Unichem's Ghaziabad plant. Active pharmaceutical ingredient Metronidazole used for this ANDA is also made in-house at Roha plant, it said.

At present, around six other companies have generic approvals for the US market and the estimated market size is over $100 million, the company added.

Shares of Unichem Laboratories were trading at Rs 216 per scrip in the afternoon trade, up 0.87 per cent from the previous close, on the BSE.

EDITORIAL OF THE DAY

  • We must understand the need for P-notes to settle the debate

    The never-ending controversy surrounding participatory notes, aka P-notes, is back in focus following the latest revelation by the Supreme Court-appoi

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Arun Kumar Jain

Managing decisions & bias in 3EE

Leadership is about facing and resolving dilemmas, taking tough calls, ...

Kuruvilla Pandikattu SJ

To see the best in the other

When two people initially develop a loving relationship, the bond ...

Dharmendra Khandal

Creepy, you say? That’s merely ophidiphobia

Snakes are the earliest predators in the life of the ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture